↓ Skip to main content

Adjusting Overall Survival Estimates for Treatment Switching in Metastatic, Castration-Sensitive Prostate Cancer: Results from the LATITUDE Study

Overview of attention for article published in Targeted Oncology, November 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
37 Mendeley
Title
Adjusting Overall Survival Estimates for Treatment Switching in Metastatic, Castration-Sensitive Prostate Cancer: Results from the LATITUDE Study
Published in
Targeted Oncology, November 2019
DOI 10.1007/s11523-019-00685-x
Pubmed ID
Authors

Susan Feyerabend, Fred Saad, Nolen Joy Perualila, Suzy Van Sanden, Joris Diels, Tetsuro Ito, Peter De Porre, Karim Fizazi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 16%
Researcher 4 11%
Other 2 5%
Lecturer 2 5%
Student > Doctoral Student 1 3%
Other 6 16%
Unknown 16 43%
Readers by discipline Count As %
Medicine and Dentistry 8 22%
Nursing and Health Professions 3 8%
Immunology and Microbiology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Unspecified 1 3%
Other 2 5%
Unknown 19 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2021.
All research outputs
#7,009,265
of 22,953,506 outputs
Outputs from Targeted Oncology
#104
of 554 outputs
Outputs of similar age
#152,195
of 456,344 outputs
Outputs of similar age from Targeted Oncology
#5
of 12 outputs
Altmetric has tracked 22,953,506 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 554 research outputs from this source. They receive a mean Attention Score of 2.8. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.